The effect of health related quality of life on reported use of health care resources in patients with osteoarthritis and rheumatoid arthritis: a longitudinal analysis.
Activities of Daily Living; Adaptation, Physiological; Adaptation, Psychological; Aged; Antirheumatic Agents/administration & dosage; Arthritis, Rheumatoid/physiopathology/therapy; Combined Modality Therapy; Confidence Intervals; Female; Health Resources/utilization; Hospitalization/statistics & numerical data; Humans; Longitudinal Studies; Male; Middle Aged; Office Visits/statistics & numerical data; Osteoarthritis/physiopathology/therapy; Patient Acceptance of Health Care/statistics & numerical data; Physical Therapy Modalities; Probability; Quality of Life; Questionnaires; Sensitivity and Specificity; Severity of Illness Index; Sickness Impact Profile; United States
Abstract :
[en] OBJECTIVE: In today's cost conscious environment, health services researchers are consistently trying to find ways to predict future health care resource utilization (HCRU) and its associated costs. We evaluated the impact of health related quality of life (HRQL) on future HCRU in patients with arthritis. METHODS: A total of 642 patients with rheumatoid arthritis (RA) and 395 patients with osteoarthritis (OA) completed at least 2 and as many as 6 consecutive surveys at 6 mo intervals. Information collected included demographics, HRQL questionnaires [Medical Outcome Study Short Form 36 (SF-36), Western Ontario McMaster Universities Osteoarthritis Index (WOMAC), and the Stanford Health Assessment Questionnaire (HAQ)], and HCRU over the previous 6 months. Longitudinal data analysis was perfomed to assess the effect of HRQL on future HCRU. RESULTS: Statistically significant associations between HCRU and HRQL variables were noted. Higher rates of HCRU were found in those in the worst quarter compared with those in the best quarter of HRQL. With the HAQ, OA and RA patients in the worst quarter reported a 199% (p < 0.05) and 48% (p < 0.05) increase in rheumatologist visits, respectively. With the WOMAC Function, increases were as high as 196% (p < 0.05) in rheumatologist visits for patients with OA. Patients with RA with a high level of HRQL as measured by the SF-36 (physical component score) reported a decrease of 31% (p < 0.01) in general practitioner visits and a decrease of 52% (p < 0.01) in hospitalization (mental component score). CONCLUSION: These findings suggest that HRQL may be used to predict future health care consumption. Such an approach may lead to a more efficient allocation of resources by providing useful information to health care providers and health care decision makers.
Disciplines :
General & internal medicine
Author, co-author :
Ethgen, Olivier ; Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique : aspects spécifiques
Kahler, Kristijan H
Kong, Sheldon X
REGINSTER, Jean-Yves ; Centre Hospitalier Universitaire de Liège - CHU > Médecine de l'appareil locomoteur
Wolfe, Frederick
Language :
English
Title :
The effect of health related quality of life on reported use of health care resources in patients with osteoarthritis and rheumatoid arthritis: a longitudinal analysis.
Publication date :
2002
Journal title :
Journal of Rheumatology
ISSN :
0315-162X
eISSN :
1499-2752
Publisher :
Journal of Rheumatology Publishing Company, Toronto, Canada
De Boer A.G.E.M., Wijtker W., De Haes H.C.J.M. (1997) Predictors of health care utilization in the chronically ill: A review of the literature. Health Policy 42:101-105.
Hulka B.S., Wheat J.R. (1985) Patterns of utilization. The patients' perspectives. Med Care 23:438-460.
Evashwick C., Rowe G., Diehr P., Branch L. (1984) Factors explaining the use of health care services by the elderly. Health Serv Res 19:357-382.
Andersen R., Newman J.F. (1973) Societal and individual determinants of medical care utilization in the United States. Milbank Q 51:95-124.
Bowling A., Brazier J. (1995) "Quality of life" in social science and medicine. Soc Sci Med 41:1337-1338.
Testa M.A., Lenderking W.R. (1992) Interpreting pharmacoeconomic and quality of life clinical trial data for use in therapeutics. Pharmacoeconomics 2:107-117.
Sherrer Y.S., Bloch D.A., Mitchell D.M., Young D.Y., Fries J.F. (1986) The development of disability in rheumatoid arthritis. Arthritis Rheum 29:494-500.
Yelin E., Lubeck D., Holman H., Epstein W. (1987) The impact of rheumatoid arthritis and osteoarthritis: The activities of patients with rheumatoid arthritis and osteoarthritis compared to controls. J Rheumatol 14:710-717.
De Bock G.H., Kaptein A.A., Touw-Otten F., Mulder J.D. (1995) Health-related quality of life in patients with osteoarthritis in a family practice setting. Arthritis Care Res 8:88-93.
Katz P.P. (1995) The impact of rheumatoid arthritis on life activities. Arthritis Care Res 8:272-278.
Wolfe F., Hawley D.J. (1993) The relationship between clinical activity and depression in rheumatoid arthritis. J Rheumatol 20:2032-2037.
Dexter P., Brandt K. (1994) Distribution and predictors of depressive symptoms in osteoarthritis. J Rheumatol 21:279-286.
Pincus T., Griffith J., Pearce S., Isenberg D. (1996) Prevalence of self-reported depression in patients with rheumatoid arthritis. Br J Rheumatol 35:879-883.
Kelsey J.L., Hochberg M.C. (1988) Epidemiology of chronic musculoskeletal disorders. Ann Rev Public Health 9:379-401.
(1994) Arthritis prevalence and activity limitations, United States 1990. Morb Mort Wkly Rep 43:433-438.
Callahan L.F., Rao J., Boutaugh M. (1996) Arthritis and women's health: Prevalence, impact and prevention. Am J Prev Med 12:401-409.
Hughes S.L., Dunlop D. (1995) The prevalence and impact of arthritis in older persons. Arthritis Care Res 8:257-264.
Lawrence R.C., Helmick C.G., Arnett F.C. (1998) Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 41:778-799.
Badley E.M., Wang P.P. (1998) Arthritis and the aging population: Projections of arthritis prevalence in Canada 1991 to 2031. J Rheumatol 25:138-144.
Lanes S.F., Lanza L.L., Radensky P.W. (1997) Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting: The importance of drug and surgery costs. Arthritis Rheum 40:1475-1481.
Badley E.M. (1995) The effect of osteoarthritis on disability and health care use in Canada. J Rheumatol 22(SUPPL. 43):19-22.
Gabriel S.E., Crowson C.S., Campion M.E., O'Fallon W.M. (1997) Direct medical costs unique to people with arthritis. J Rheumatol 24:719-725.
Yelin E., Wanke L.A. (1999) An assessment of the annual and long-term direct costs of rheumatoid arthritis. The impact of poor function and functional decline. Arthritis Rheum 42:1209-1218.
Gabriel S.E., Crowson C.S., Campion M.E., O'Fallon W.M. (1997) Indirect and nonmedical costs among people with rheumatoid arthritis and osteoarthritis compared with nonarthritic controls. J Rheumatol 24:43-48.
Gabriel S.E., Crowson C.S., O'Fallon W.M. (1995) Costs of osteoarthritis: Estimates from a geographically defined population. J Rheumatol 22(SUPPL. 43):23-25.
Wolfe F., Hawley D.J. (1998) The longterm outcomes of rheumatoid arthritis: Work disability: A prospective 18 years study of 823 patients. J Rheumatol 25:2108-2117.
Cronan T.A., Shaw W.S., Gallagher R.A., Weisman M. (1995) Predicting health care use among older osteoarthritis patients in an HMO. Arthritis Care Res 8:66-72.
Berkanovic E., Hurwicz M.L. (1995) Physician visits by rheumatoid arthritis patients: A prospective analysis. Arthritis Care Res 8:73-79.
Hopman-Rock M., De Bock G.H., Bijlsma J.W.J., Springer M.P., Hofman A., Kraaimaat F.W. (1997) The pattern of health care utilization of elderly people with arthritic pain in the hip or knee. Int J Qual Health Care 9:129-137.
Hawley D.J., Wolfe F. (1988) Anxiety and depression in patients with rheumatoid arthritis: A prospective study of 400 patients. J Rheumatol 15:932-941.
Katz P.P., Yelin E. (1993) Prevalence and correlates of depressive symptoms among persons with rheumatoid arthritis. J Rheumatol 20:790-796.
Lubeck D.P., Spitz P.W., Fries J.F., Wolfe F., Mitchell D.M., Roth S.H. (1986) A multicenter study of annual health service utilization and costs in rheumatoid arthritis. Arthritis Rheum 29:488-493.
Singh G., Terry R., Ramey D., Wolfe F., Fries J. (1996) Long-term medical costs and outcomes are significantly associated with early changes in disability in rheumatoid arthritis. Arthritis Rheum 39(SUPPL.).
Clarke A.E., Levinton C., Joseph L. (1999) Predicting the short term direct medical costs incurred by patients with rheumatoid arthritis. J Rheumatol 26:1068-1075.
Blais R. (1994) Variations in the use of healthcare services: Why are more studies needed?. CMAJ 151:1701-1703.
Wolfe F., Zwillich S.H. (1998) The long-term outcomes of rheumatoid arthritis: A 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis. Arthritis Rheum 41:1072-1082.
Ropes M.W., Bennett G.A., Cobb S., Jacox R., Jessar R.A. (1959) 1958 Revision of diagnostic criteria for rheumatoid arthritis. Arthritis Rheum 2:16-20.
Arnett F.C., Edworthy S.M., Bloch D.A. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324.
Altman R., Asch E., Bloch D.A. (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum 29:1039-1049.
Altman R., Alarcon G.C., Appelrouth D. (1991) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 34:505-514.
Wolfe F., Anderson J., Harkness D. (1997) A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum 40:1560-1570.
Ware J.E. Jr., Krinstin K.S., Kosinski M., Gandek B. SF-36 Health Survey. Manual and interpretation guide, Boston: New England Medical Center, The Health Institute; 1993.
Ware J.E. Jr., Kosinski M., Keller S.D. SF-36 Physical and Mental summary scales: A user's manual, Boston: New England Medical Center, The Health Institute; 1994.
Ware J.E. Jr. (1996) The SF-36 Health Survey. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. , Spilker B, editor. Philadelphia: Lippincott-Raven; 337-345.
McHorney C.A., Ware J.E. Jr., Lu J.F., Sherbourne C.D. (1994) The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 32:40-66.
Tuttleman M., Pillemer S.R., Tilley B.C. (1997) A cross sectional assessment of health status instruments in patients with rheumatoid arthritis participating in a clinical trial. J Rheumatol , Minocycline in Rheumatoid Arthritis Trial Group; 24:1910-1915.
Ruta D.A., Hurst N.P., Kind P., Hunter M., Stubbings A. (1998) Measuring health status in British patients with rheumatoid arthritis: Reliability, validity and responsiveness of the short form 36-item health survey (SF-36). Br J Rheumatol 37:425-436.
Kosinski M., Keller S.D., Hatoum H.T., Kong S.X., Ware J.E. Jr. (1999) The SF-36 health survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis. Tests of data quality, scaling assumptions and score reliability. Med Care 37.
Kosinski M., Keller S.D., Ware J.E. Jr., Hatoum H.T., Kong S.X. (1999) The SF-36 health survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis. Relative validity of scales in relation to clinical measures of arthritis severity. Med Care 37.
Fries J.F., Spitz P.W., Kraines R.G., Holman H.R. (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23:137-145.
Fries J.F., Spitz P.W., Young D.Y. (1982) The dimensions of health outcomes: The Health Assessment Questionnaire, disability and pain scales. J Rheumatol 9:1789-1793.
Ramey D.R., Raynauld J.P., Fries J.F. (1992) The Health Assessment Questionnaire 1992 - Status and review. Arthritis Care Res 5:119-129.
Ramey D.R., Fries J.F., Singh G. (1996) The Health Assessment Questionnaire 1995 - Status and review. Quality of life and pharmacoeconomics in clinical trials. 2nd ed. , Spilker B, editor. Philadelphia: Lippincott-Raven; 227-237.
Bellamy N. WOMAC Osteoarthritis Index. A user's guide, London, Ontario: University of Western Ontario; 1995.
Bellamy N., Buchanan W.W., Goldsmith C.H., Campbell J., Stitt L.W. (1988) Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15:1833-1840.
Bellamy N., Buchanan W.W., Goldsmith C.H., Campbell J., Stitt L.W. (1988) Validation study of WOMAC: A health status instrument for measuring clinically-important patient-relevant outcomes following total hip or knee arthroplasty in osteoarthritis. J Orthop Rheum 1:95-108.
Bellamy N., Kean W.F., Buchanan W.W., Gerecz-Simon E., Campbell J. (1992) Double blind randomized controlled trial of sodium meclofenamate (Meclomen) and diclofenac sodium (Voltaren): Post validation reapplication of the WOMAC Osteoarthritis Index. J Rheumatol 19:153-159.
Wolfe F. (1999) Determinants of WOMAC Function, pain and stiffness scores: Evidence for the role of low back pain, symptom counts, fatigue and depression in osteoarthritis, rheumatoid arthritis and fibromyalgia. Rheumatology 38:355-361.
Wolfe F., Kong S.X. (1999) Rasch analysis of the Western Ontario McMaster Questionnaire (WOMAC) in 2205 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Ann Rheum Dis 58:563-568.
Liang K.-Y., Zeger S.L. (1986) Longitudinal data analysis using generalized linear models. Biometrika 73:13-22.
Zeger S.L., Liang K.-Y. (1986) Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42:121-130.
Stata statistical software, Reference guide 6.0, College Station, TX: Stata Corp.; 1999.
Suarez-Almazor M.E., Soskolne C.L., Saunders L.D., Russell A.S. (1994) Outcome in rheumatoid arthritis. A 1985 inception cohort study. J Rheumatol 21:1438-1446.
Smedstad L.M., Mourn T., Guillemin F. (1996) Correlates of functional disability in early rheumatoid arthritis: A cross-sectional study of 706 patients in four European countries. Br J Rheumatol 35:746-751.
Mazzuca S.A., Brandt K.D., Katz B.P., Hanna M.P., Melfi C.A. (1999) Reduced utilization and cost of primary care visits resulting from self-care education for patients with osteoarthritis of the knee. Arthritis Rheum 42:1267-1273.
